RA Capital Management

About

Portfolio · 5

Innoventric

Transcatheter Solution for Tricuspid Regurgitation

Led ★ 1 round $28.5M committed Latest: 2024-10

UroGen Pharma

Urologic Oncology Therapies

Led ★ 1 round $120.0M committed Latest: 2023-07

Nucleix

Noninvasive Testing for Early Detection of Cancer

2 rounds $77.0M committed Latest: 2022-01

WhiteSwell Medical

Acute Decompensated Heart Failure Treatment

1 round $30.0M committed Latest: 2018-12

89bio

Treatment for Liver and Metabolic Disorders

1 round $60.0M committed Latest: 2018-10

Investment activity

1 portfolio exit on record.

Q&A

What is RA Capital Management's primary investment focus?

RA Capital Management primarily focuses on the healthcare and life sciences sectors, investing across all stages of company development, from early-stage startups to publicly traded entities. Their emphasis is on therapeutics, diagnostics, and medical technologies.

Which notable companies are in RA Capital Management's portfolio?

RA Capital Management's portfolio includes companies such as 89bio, which focuses on treatments for liver and metabolic disorders, and Nucleix, which develops noninvasive tests for the early detection of cancer.

Has RA Capital Management had any notable exits?

Yes, RA Capital Management had an exit in November 2019 when 89bio, a company focused on treatments for liver and metabolic disorders, went public on NASDAQ after raising $85M in capital.

What investment stages does RA Capital Management typically participate in?

RA Capital Management participates in a wide range of investment stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, G Round, and PIPE.

When was RA Capital Management founded?

RA Capital Management was founded in 2001.

Who are the managing partners at RA Capital Management?

The managing partners at RA Capital Management include Peter Kolchinsky, who is also a founder, and Rajeev Shah.

What is RA Capital Management's approach to company development?

In addition to passive investment, RA Capital Management is actively involved in company creation, partnering with scientific and executive teams to build ventures that target unmet medical needs. They also leverage a dedicated research unit, TechAtlas, for data-driven decision-making.

What is the most recent investment activity by RA Capital Management?

RA Capital Management made an investment in October 2024, according to startupim data.